Literature DB >> 26852162

Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis.

Marina Naldi1, Maurizio Baldassarre2, Marco Domenicali2, Ferdinando Antonino Giannone2, Matteo Bossi3, Jonathan Montomoli4, Thomas Damgaard Sandahl4, Emilie Glavind4, Hendrik Vilstrup4, Paolo Caraceni2, Carlo Bertucci5.   

Abstract

Human serum albumin (HSA) is the most abundant plasma protein, endowed with several biological properties unrelated to its oncotic power, such as antioxidant and free-radicals scavenging activities, binding and transport of many endogenous and exogenous substances, and regulation of endothelial function and inflammatory response. These non-oncotic activities are closely connected to the peculiarly dynamic structure of the albumin molecule. HSA undergoes spontaneous structural modifications, mainly by reaction with oxidants and saccharides; however, patients with cirrhosis show extensive post-transcriptional changes at several molecular sites of HSA, the degree of which parallels the severity of the disease. The present work reports the development and application of an innovative LC-MS analytical method for a rapid and reproducible determination of the relative abundance of HSA isoforms in plasma samples from alcoholic hepatitis (AH) patients. A condition of severe oxidative stress, similar to that observed in AH patients, is associated with profound changes in circulating HSA microheterogeneity. More interestingly, the high resolution provided by the analytical platform allowed the monitoring of novel oxidative products of HSA never reported before.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcoholic hepatitis; Human serum albumin isoforms; Mass spectrometry; Post-translational modifications

Mesh:

Substances:

Year:  2016        PMID: 26852162     DOI: 10.1016/j.jpba.2016.01.048

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Human serum albumin presents isoform variants with altered neonatal Fc receptor interactions.

Authors:  Yann Leblanc; Marie Berger; Alexander Seifert; Nicolas Bihoreau; Guillaume Chevreux
Journal:  Protein Sci       Date:  2019-11       Impact factor: 6.725

2.  Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications.

Authors:  Maurizio Baldassarre; Marina Naldi; Mauro Bernardi; Paolo Caraceni; Giacomo Zaccherini; Michele Bartoletti; Agnese Antognoli; Maristella Laggetta; Martina Gagliardi; Manuel Tufoni; Marco Domenicali; Katja Waterstradt; Paola Paterini; Anna Baldan; Simona Leoni; Manuela Bartolini; Pierluigi Viale; Franco Trevisani
Journal:  Hepatology       Date:  2021-05-26       Impact factor: 17.425

Review 3.  Reproducibility2020: Progress and priorities.

Authors:  Leonard P Freedman; Gautham Venugopalan; Rosann Wisman
Journal:  F1000Res       Date:  2017-05-02

Review 4.  Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease.

Authors:  Manuel Tufoni; Maurizio Baldassarre; Giacomo Zaccherini; Agnese Antognoli; Paolo Caraceni
Journal:  Curr Hepatol Rep       Date:  2020-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.